Freund Corp
TSE:6312

Watchlist Manager
Freund Corp Logo
Freund Corp
TSE:6312
Watchlist
Price: 1 078 JPY 0.09% Market Closed
Market Cap: ¥19.8B

Freund Corp
Accrued Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Freund Corp
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Freund Corp
TSE:6312
Accrued Liabilities
¥209.2m
CAGR 3-Years
18%
CAGR 5-Years
8%
CAGR 10-Years
1%
Mitsubishi Heavy Industries Ltd
TSE:7011
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fujitec Co Ltd
TSE:6406
Accrued Liabilities
¥2.8B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Fanuc Corp
TSE:6954
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Star Micronics Co Ltd
TSE:7718
Accrued Liabilities
¥1.1B
CAGR 3-Years
-10%
CAGR 5-Years
10%
CAGR 10-Years
6%
I
Ishii Iron Works Co Ltd
TSE:6362
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Freund Corp
Glance View

Market Cap
19.8B JPY
Industry
Machinery

Freund Corp. engages in the development, manufacture, and sale of granulation and coating equipment for pharmaceutical, food, and chemical industries. The company is headquartered in Shinjuku, Tokyo-To. The firm operates through two business segments. The Machinery segment is engaged in the manufacture and sale of powder and granular machinery, measuring instrument and components, the construction of granular machinery plants, as well as the contracted manufacture of fine grinding of synthetic resin. The Chemical Product segment is involved in the manufacture and sale of pharmaceutical excipients and nutritious supplements, the manufacture of food preservatives, the development and research of pharmaceuticals, food and chemicals, the review of prescriptions, the contacted manufacture and brokerage of study drugs, as well as the development and technology licensing of new dosage forms.

Intrinsic Value
1 068.87 JPY
Overvaluation 1%
Intrinsic Value
Price ¥1 078

See Also

What is Freund Corp's Accrued Liabilities?
Accrued Liabilities
209.2m JPY

Based on the financial report for Nov 30, 2025, Freund Corp's Accrued Liabilities amounts to 209.2m JPY.

What is Freund Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
1%

Over the last year, the Accrued Liabilities growth was 39%. The average annual Accrued Liabilities growth rates for Freund Corp have been 18% over the past three years , 8% over the past five years , and 1% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett